Modulation of dendritic cell and T cell cross-talk during aging: The potential role of checkpoint inhibitory molecules
MetadataShow full item record
© 2017 Elsevier B.V. Dendritic cells (DCs) undergo continuous changes throughout life, and there is evidence that elderly DCs have a reduced capacity to stimulate T cells, which may contribute to impaired anti-tumour immune responses in elderly people with cancer. Changes in checkpoint inhibitory molecules/pathways during aging may be one mechanism that impairs the ability of elderly DCs to activate T cells. However, little is currently known regarding the combined effects of aging and cancer on DC and T cell inhibitory molecules/pathways. In this review, we discuss our current understanding of the influence of aging and cancer on key DC and T cell inhibitory molecules/pathways, the potential underlying cellular and molecular mechanisms contributing to their modulation, and the possibility of therapeutically targeting inhibitory molecules in elderly cancer patients.
Showing items related by title, author, creator and subject.
Elsegood, Caryn; Tirnitz-Parker, Nina; Olynyk, John; Yeoh, G. (2017)The global prevalence of liver cancer is rapidly rising, mostly as a result of the amplified incidence rates of viral hepatitis, alcohol abuse and obesity in recent decades. Treatment options for liver cancer are remarkably ...
The Regulatory Status Adopted by Lymph Node Dendritic Cells and T Cells During Healthy Aging Is Maintained During Cancer and May Contribute to Reduced Responses to ImmunotherapyGardner, J.; Jackaman, Connie; Mamotte, C.; Nelson, Delia (2018)Aging is associated with an increased incidence of cancer. One contributing factor could be modulation of immune cells responsible for anti-tumor responses, such as dendritic cells (DCs) and T cells. These immunological ...
Fox, Simon; Richards, Alex; Kusumah, Ivonne; Perumal, Vanathi; Bolitho, Erin; Mutsaers, S.; Dharmarajan, A. (2013)Malignant mesothelioma (MM) is an uncommon and particularly aggressive cancer associated with 29asbestos exposure, which currently presents an intractable clinical challenge. Wnt signaling has been reported to play a role ...